Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced advancements to its unified AI framework for drug target discovery, ...
insights from industryStephan Brock, Alessandro Cinti & Samuel Bradberry Co-founder/CTO, Scientific Research Expert, Principal ScientistMolecular Health and Axxam In this interview, News Medical ...
Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
How do you begin the discovery phase of drug development? The first stages are target identification and validation. This involves selecting a target, such as a protein, receptor, or enzyme, and ...
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results